Send to

Choose Destination
See comment in PubMed Commons below
Sci Transl Med. 2010 Oct 27;2(55):55ps52. doi: 10.1126/scitranslmed.3001722.

ICOStomizing immunotherapies with T(H)17.

Author information

  • 1Immunology Institute, Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA.


New insights on the role of costimulatory molecules in T helper cell function have yielded exciting alternatives to the development of therapeutic strategies that target T cell costimulatory pathways. Inducible costimulatory molecule (ICOS) signaling is now shown by Paulos and colleagues to support expansion of human T helper 17 (T(H)17) cells that could exert antitumor activity. Here we discuss (i) how these findings aid in our understanding of mechanisms that govern T(H)17 cell functions and (ii) the potential application of these new insights to the development of immunotherapies.

[PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center